HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First Evidence for a Role of Siglec-8 in Breast Cancer.

Abstract
Sialic acid-binding immunoglobulin-like lectins (Siglecs) are involved in various immune cell-mediated diseases. Their role in cancer is poorly investigated, and research focusses on Siglec-expression on immune cells interacting with tumor cells. This study evaluates the role of Siglec-8 in breast cancer (BC). Siglec-8 expression was analyzed immunohistochemically on 235 primary BC cases and was correlated with clinical and pathological parameters and outcome. Cell culture experiments were performed with various BC cell lines. Siglec-8 was expressed in 215 BC cases and expression was lowest in triple-negative BC. It correlated with estrogen receptor-status, grading and the prognostic factors galectin (Gal)-7 and tumor-associated mucin-1 (TA-MUC1). However, Gal-7 and TA-MUC1 were only prognosticators for clinical outcome in the cohort expressing high (Immunoreactivity score IRS > 3) Siglec-8 levels but not in the low-expressing cohort. Siglec-8 knockdown led to a significantly reduced Gal-7 expression in MCF7 cells. All BC cell lines expressed low Siglec-8-levels, that could be elevated in MCF7 by Peroxisome proliferator-activated receptor (PPARĪ³)-stimulation. This study demonstrates that Siglec-8 is expressed in BC cells and correlates with known clinical and prognostic parameters. It is probably associated with Gal-7 and TA-MUC1 and might be regulated via PPARĪ³. Further analyses focusing on functional associations will clarify Siglec-8's eligibility as a possible therapeutic target.
AuthorsAnna Trebo, Nina Ditsch, Tom Degenhardt, Christina Kuhn, Martina Rahmeh, Elisa Schmoeckel, Doris Mayr, Bastian Czogalla, Thomas Kolben, Sarah Meister, Sven Mahner, Udo Jeschke, Anna Hester
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 4 (Feb 18 2021) ISSN: 1422-0067 [Electronic] Switzerland
PMID33670444 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, B-Lymphocyte
  • Galectins
  • LGALS7 protein, human
  • Lectins
  • MUC1 protein, human
  • Mucin-1
  • Receptors, Estrogen
  • SIGLEC8 protein, human
Topics
  • Adult
  • Aged
  • Antigens, CD (biosynthesis, genetics)
  • Antigens, Differentiation, B-Lymphocyte (biosynthesis, genetics)
  • Breast Neoplasms (diagnosis, genetics, metabolism)
  • Cell Line, Tumor
  • Galectins (biosynthesis)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry (methods)
  • Lectins (biosynthesis, genetics)
  • MCF-7 Cells
  • Middle Aged
  • Mucin-1 (biosynthesis)
  • Neoplasm Grading
  • Prognosis
  • Receptors, Estrogen (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: